News - PharmaNL

Meet PharmaNL: Yorick Peterse (Ministry of Health, Welfare and Sport). “PharmaNL brings together patient care and economic growth”

March 31, 2026

In the Meet PharmaNL series, we introduce the board, partners such as ZonMw, and policymakers who contribute to PharmaNL’s ambitions. The Dutch Ministry of Health, Welfare and Sport (VWS) plays a key role in this effort. With expertise in pharmaceutical policy, innovation, and the coordination of funding, VWS contributes to a strong and future-proof pharmaceutical […]

Modeling for Better Medicines: QPharmNL Project Launches

March 23, 2026

The recently awarded QPharmNL project, part of the PharmaNL Human Capital Growth (HCG) program, will launch in April 2026 with an innovative training program focused on computational pharmacological techniques in drug development. These techniques use mathematical models to map the relationship between dose, exposure, effects, and side effects of new medicines, enabling better translation of […]

From Lab to Practice: New Post-Bachelor ATMP Courses

March 3, 2026

Training professionals for Advanced Therapeutic Medicinal Products (ATMPs) is at the heart of one of the newest PharmaNL projects. In the recent October 2025 funding round, ZonMw awarded six projects within the Human Capital Growth program line of PharmaNL, aimed at strengthening the knowledge and skills of professionals in the pharmaceutical sector. One of these […]

Four New Projects Launch under Shared Development Infrastructure

February 26, 2026

In the coming months, four new projects will get underway as part of the PharmaNL Shared Development Infrastructure (SDI) Call 2025, the second funding round within the PharmaNL SDI program line. The selected projects focus on building and/or upgrading infrastructure for the development, scale-up, and production of innovative medicines in the Netherlands. A total of […]

Call for Companies: Pilot Participation in Gentech and Bioanalysis Modules

February 19, 2026

Would your organisation like to train employees and introduce them to the latest developments in Gentech and Bioanalysis? The PharmaNL project Groningen Human Capital for Life Sciences invites companies to participate in the pilot phase of newly developed training modules. This project, part of PharmaNL’s Human Capital Growth programme line, focuses on developing innovative training […]

Flexible Education in Advanced Therapeutics for Life Sciences Professionals

February 11, 2026

In October 2025, ZonMw approved six projects within PharmaNL’s Human Capital Growth programme line, aimed at strengthening the knowledge and skills of professionals in the pharmaceutical sector. One of these projects now in the spotlight is PEAT – Post-initial Education in Advanced Therapeutics. Roland Brock, Professor of Biochemistry at Radboudumc and project leader of PEAT, […]

Nanoworx Milestones: New Infrastructure and First Commercial Projects

How can we better harness the potential of nanomedicine? Nanoworx, one of the projects funded under PharmaNL’s Shared Development Infrastructure program, was established as a new Contract Research Organisation (CRO) to automate and accelerate the development of innovative nanomedicines. With support from PharmaNL and TU/e, Nanoworx is building a sustainable infrastructure to create nanomedicine libraries […]

Four Years of Connecting: The Farewell of Hubertus Irth, a Driving Force Behind PharmaNL

January 29, 2026

After nearly four years, Hubertus Irth is stepping down as a board member of PharmaNL, the national pharmaceutical programme made possible in part by funding from the Dutch National Growth Fund. As an academic and one of the programme’s founders, he played a key role in shaping the consortium, which brings together Leiden University / […]

Today’s input, tomorrow’s impact: PharmaNL Expert Event Human Capital Growth

January 27, 2026

Yesterday, PharmaNL’s Expert Event Human Capital Growth took place at the Jaarbeurs in Utrecht. The event offered participants a valuable platform to discuss priorities and challenges related to Human Capital in the pharmaceutical sector and to support the revision of the PharmaNL Investment Agenda. The programme opened with a warm welcome by Jon de Vlieger […]

Innovation in action: video National Growth Fund

December 9, 2025

What does PharmaNL actually stand for? In this short video, produced by the National Growth Fund, Board Member Ton Vries explains how we connect knowledge institutions, companies, and start-ups. This collaboration helps innovative medicines and production technologies move faster from idea to production. By investing in R&D infrastructure and training, we position the Netherlands as […]